Participation of 5-lipoxygenase-derived LTB4 in 4-hydroxynonenal-enhanced MMP-2 production in vascular smooth muscle cells

Seo, Kyo W.; Lee, Seung J.; Kim, Chae E.; Yun, Mi R.; Park, Hye M.; Yun, Jung W.; Bae, Sun S.; Kim, Chi D.

doi:10.1016/j.atherosclerosis.2009.06.012

« Previous Next »Atherosclerosis
Volume 208, Issue 1 , Pages 56-61, January 2010

Participation of 5-lipoxygenase-derived LTB₄ in 4-hydroxynonenal-enhanced MMP-2 production in vascular smooth muscle cells

Kyo W. Seo
- MRC for Ischemic Tissue Regeneration and Medical Research Institute, Pusan National University, Yangsan, Gyeongnam 626-770, Republic of Korea
- Department of Pharmacology and BK21 Medical Science Education Center, School of Medicine, Pusan National University, Yangsan, Gyeongnam 626-770, Republic of Korea
- Both authors contributed equally to this work.
Seung J. Lee
- MRC for Ischemic Tissue Regeneration and Medical Research Institute, Pusan National University, Yangsan, Gyeongnam 626-770, Republic of Korea
- Department of Pharmacology and BK21 Medical Science Education Center, School of Medicine, Pusan National University, Yangsan, Gyeongnam 626-770, Republic of Korea
- Both authors contributed equally to this work.
Chae E. Kim
- MRC for Ischemic Tissue Regeneration and Medical Research Institute, Pusan National University, Yangsan, Gyeongnam 626-770, Republic of Korea
- Department of Pharmacology and BK21 Medical Science Education Center, School of Medicine, Pusan National University, Yangsan, Gyeongnam 626-770, Republic of Korea
Mi R. Yun
- MRC for Ischemic Tissue Regeneration and Medical Research Institute, Pusan National University, Yangsan, Gyeongnam 626-770, Republic of Korea
- Department of Pharmacology and BK21 Medical Science Education Center, School of Medicine, Pusan National University, Yangsan, Gyeongnam 626-770, Republic of Korea
Hye M. Park
- MRC for Ischemic Tissue Regeneration and Medical Research Institute, Pusan National University, Yangsan, Gyeongnam 626-770, Republic of Korea
- Department of Pharmacology and BK21 Medical Science Education Center, School of Medicine, Pusan National University, Yangsan, Gyeongnam 626-770, Republic of Korea
Jung W. Yun
- MRC for Ischemic Tissue Regeneration and Medical Research Institute, Pusan National University, Yangsan, Gyeongnam 626-770, Republic of Korea
- Department of Pharmacology and BK21 Medical Science Education Center, School of Medicine, Pusan National University, Yangsan, Gyeongnam 626-770, Republic of Korea
Sun S. Bae
- MRC for Ischemic Tissue Regeneration and Medical Research Institute, Pusan National University, Yangsan, Gyeongnam 626-770, Republic of Korea
- Department of Pharmacology and BK21 Medical Science Education Center, School of Medicine, Pusan National University, Yangsan, Gyeongnam 626-770, Republic of Korea
Chi D. Kim
- MRC for Ischemic Tissue Regeneration and Medical Research Institute, Pusan National University, Yangsan, Gyeongnam 626-770, Republic of Korea
- Department of Pharmacology and BK21 Medical Science Education Center, School of Medicine, Pusan National University, Yangsan, Gyeongnam 626-770, Republic of Korea
- Corresponding author at: Department of Pharmacology, School of Medicine, Pusan National University, Yangsan, Gyeongnam 626-770, Republic of Korea. Tel.: +82 51 510 8063; fax: +82 51 510 8068.